EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Squalenoylated Temozolomide Nanoparticle with Long Circulating Properties Reverses Drug Resistance in Glioblastoma

Jiao Feng iD, Chengyong Wen iD, Xiao Zhang, Xiaolong Zhu, Mengmeng Ma, Xiaohong Zhao, Xinbing Sui

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26104723 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jiao Feng und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China. Hauptthemen laut MEDLINE: Temozolomide, Glioblastoma, Drug Resistance, Neoplasm, Nanoparticles. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Temozolomide (TMZ) remains the frontline chemotherapy for gliomas; yet its clinical efficacy is significantly compromised by inherent instability and the emergence of resistance mechanisms. To surmount these challenges, we engineered a squalenoylated TMZ nanoparticle (SQ-TMZ NPs) via conjugation of TMZ with squalene, enabling enhanced drug stability and improved therapeutic potency against glioblastoma cells. The resulting SQ-TMZ NPs exhibited a precisely controlled nanoscale architecture (~126 nm), demonstrating exceptional stability under physiological and storage conditions, with minimal hemolytic toxicity (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TemozolomideGlioblastomaDrug Resistance, NeoplasmNanoparticlesSqualeneAntineoplastic Agents, AlkylatingBrain NeoplasmsHumansCell Line, TumorAnimalsBlood-Brain BarrierMiceReactive Oxygen Species

Stichwörter der Autor:innen

MGMT expressionglioblastomasqualenoylationtemozolomide resistance

Substanzen

TemozolomideSqualeneAntineoplastic Agents, AlkylatingReactive Oxygen Species

Autor:innen und Institutionen

  • School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China.
  • Shuren College, Zhejiang Chinese Medical University, Hangzhou 310053, China.

ORCID-Profile: Jiao Feng, Chengyong Wen

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Feng, J., Wen, C., Zhang, X., Zhu, X., Ma, M., Zhao, X., & Sui, X. (2025). A Novel Squalenoylated Temozolomide Nanoparticle with Long Circulating Properties Reverses Drug Resistance in Glioblastoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26104723

Vancouver

Feng J, Wen C, Zhang X, Zhu X, Ma M, Zhao X, et al. A Novel Squalenoylated Temozolomide Nanoparticle with Long Circulating Properties Reverses Drug Resistance in Glioblastoma. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26104723

BibTeX
@article{Feng2025,
  author = {Feng, Jiao and Wen, Chengyong and Zhang, Xiao and Zhu, Xiaolong and Ma, Mengmeng and Zhao, Xiaohong and Sui, Xinbing},
  title = {A Novel Squalenoylated Temozolomide Nanoparticle with Long Circulating Properties Reverses Drug Resistance in Glioblastoma},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26104723}
}
Kostenlos starten →